[go: up one dir, main page]

AU7198291A - Human monoclonal antibodies against rabies viruses, the production and the use thereof - Google Patents

Human monoclonal antibodies against rabies viruses, the production and the use thereof

Info

Publication number
AU7198291A
AU7198291A AU71982/91A AU7198291A AU7198291A AU 7198291 A AU7198291 A AU 7198291A AU 71982/91 A AU71982/91 A AU 71982/91A AU 7198291 A AU7198291 A AU 7198291A AU 7198291 A AU7198291 A AU 7198291A
Authority
AU
Australia
Prior art keywords
production
monoclonal antibodies
antibodies against
human monoclonal
rabies viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU71982/91A
Other versions
AU634030B2 (en
Inventor
Karlheinz Enssle
Joachim Hilfenhaus
Roland Kohler
Roland Kurrle
Friedrich-Robert Seiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU7198291A publication Critical patent/AU7198291A/en
Application granted granted Critical
Publication of AU634030B2 publication Critical patent/AU634030B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU71982/91A 1990-03-03 1991-03-01 Human monoclonal antibodies against rabies viruses, the production and the use thereof Ceased AU634030B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4006630 1990-03-03
DE4006630A DE4006630A1 (en) 1990-03-03 1990-03-03 HUMANE MONOCLONAL ANTIBODIES AGAINST RABBIT VIRUSES, THEIR PRODUCTION AND USE

Publications (2)

Publication Number Publication Date
AU7198291A true AU7198291A (en) 1991-09-05
AU634030B2 AU634030B2 (en) 1993-02-11

Family

ID=6401309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71982/91A Ceased AU634030B2 (en) 1990-03-03 1991-03-01 Human monoclonal antibodies against rabies viruses, the production and the use thereof

Country Status (8)

Country Link
EP (1) EP0445625A1 (en)
JP (1) JPH05301894A (en)
KR (1) KR910016346A (en)
AU (1) AU634030B2 (en)
CA (1) CA2037446A1 (en)
DE (1) DE4006630A1 (en)
IE (1) IE910697A1 (en)
PT (1) PT96908A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579446B2 (en) 2004-05-27 2009-08-25 Crucell Holland B.V. Binding molecules capable of neutralizing rabies virus and uses thereof
US7959922B2 (en) 2006-12-05 2011-06-14 Crucell Holland B.V. Liquid anti-rabies antibody formulations
US8211431B2 (en) 2006-06-06 2012-07-03 Crucell Holland B.V. Human binding molecules having killing activity against staphylococci and uses thereof

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2344208A1 (en) 2001-04-30 2002-10-30 Oxford Biomedica (Uk) Limited Method
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
EP1523329B1 (en) 2002-07-05 2013-07-24 Folia Biotech Inc. Adjuvant viral particle
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
JP4836451B2 (en) 2002-07-18 2011-12-14 メルス ベー ヴェー Recombinant production of antibody mixtures
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
EP1737971B1 (en) 2004-01-20 2017-08-16 Merus N.V. Mixtures of binding proteins
GB0526210D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Vectors
PL3192874T3 (en) 2008-06-18 2020-06-29 Oxford Biomedica (Uk) Limited Virus purification
JP2010085126A (en) * 2008-09-29 2010-04-15 Adtec Kk Determination instrument for determining neutralizing antibody titer of rabies virus, and method for measuring neutralizing antibody titer of rabies virus
ES2536791T3 (en) 2010-05-28 2015-05-28 Oxford Biomedica (Uk) Ltd Administration of lentiviral vectors to the brain
GB201118636D0 (en) 2011-10-28 2011-12-07 Oxford Biomedica Ltd Nucleotide sequence
CA2871068C (en) 2012-04-20 2022-06-14 Merus B.V. Methods and means for the production of ig-like molecules
CN103954777A (en) * 2014-05-20 2014-07-30 北京凯思百奥科技发展有限公司 Rabies virus monoclonal antibody and application thereof
WO2019227039A1 (en) * 2018-05-24 2019-11-28 Lankenau Institute For Medical Research Compositions comprising antibodies to rabies virus and the uses thereof
CA3133188A1 (en) 2019-03-10 2020-09-17 Oxford Biomedica (Uk) Limited Gene therapy compositions and methods for treating parkinson's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131878A3 (en) * 1983-07-19 1987-08-05 Sloan-Kettering Institute For Cancer Research Process for producing human monoclonal antibodies
WO1989009789A1 (en) * 1988-04-07 1989-10-19 Farmitalia Carlo Erba S.R.L. Human monoclonal antibodies against rabies virus
DE69005908T2 (en) * 1989-06-08 1994-04-28 Wistar Inst Philadelphia Monoclonal antibodies for treatment after contact with rabies virus.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579446B2 (en) 2004-05-27 2009-08-25 Crucell Holland B.V. Binding molecules capable of neutralizing rabies virus and uses thereof
US7740852B2 (en) 2004-05-27 2010-06-22 Crucell Holland B.V. Binding molecules capable of neutralizing rabies virus and uses thereof
US8148497B2 (en) 2004-05-27 2012-04-03 Crucell Holland B.V. Binding molecules capable of neutralizing rabies virus and uses thereof
US9005624B2 (en) 2004-05-27 2015-04-14 Crucell Holland B.V. Binding molecules capable of neutralizing rabies virus and uses thereof
US8211431B2 (en) 2006-06-06 2012-07-03 Crucell Holland B.V. Human binding molecules having killing activity against staphylococci and uses thereof
US8460666B2 (en) 2006-06-06 2013-06-11 Crucell Holland B.V. Human binding molecules having killing activity against staphylococci and uses thereof
US7959922B2 (en) 2006-12-05 2011-06-14 Crucell Holland B.V. Liquid anti-rabies antibody formulations

Also Published As

Publication number Publication date
CA2037446A1 (en) 1991-09-04
JPH05301894A (en) 1993-11-16
EP0445625A1 (en) 1991-09-11
KR910016346A (en) 1991-11-05
PT96908A (en) 1991-10-31
AU634030B2 (en) 1993-02-11
DE4006630A1 (en) 1991-09-12
IE910697A1 (en) 1991-09-11

Similar Documents

Publication Publication Date Title
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
IL101690A0 (en) Antibodies and methods utilizing the same
EP0777497A4 (en) HUMAN, THE HIV VIRUS NEUTRALIZING, MONOCLONAL ANTIBODIES
ZA964710B (en) Novel compounds, the preparation and use thereof.
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
EP0468464A3 (en) Cellulase, method for producing the same and use thereof
AU9075591A (en) N-halochitosans, their preparation and uses
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
EP0245993A3 (en) Monoclonal antibodies against c5a and des-arg74-c5a, their production and use
EP0805161A4 (en) (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
AU1140197A (en) Pyridyl carbamates, process and intermediates for the preparation and use thereof
GB2246139B (en) Polytheresters,their production and use
AU3064495A (en) UV absorbers, their preparation and the use thereof
EP0622369A3 (en) 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof.
AU8876591A (en) Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
AU8271191A (en) Indolonaphthyridines, their production and use
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
AU7504691A (en) Monoclonal antibodies against pp4, processes for the preapration thereof and the use thereof
AU4174789A (en) Hybrid monoclonal antibodies, their production and use
AU9139591A (en) Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof
AU3432389A (en) Human monoclonal antibodies against rabies virus
AU4314693A (en) Pyrimidinyl- and triazinyl- salicyl- and picolylamides and the use, as herbicides, and preparation thereof
ZA9610510B (en) Novel peptides, the preparation and use thereof.